GLP-1 Analogs for Therapy of Multiple Sclerosis (MSGLP): Design, Methods and Rationale of Randomized, Controlled Clinical Trial

被引：0
|
作者：
Imrich, Richard [1 ]
Penesova, Adela [1 ]
Vlcek, Miroslav [1 ]
Radikova, Zofia [1 ]
Havranova, Andrea [1 ]
Siarnik, Pavol [2 ]
Sivakova, Monika [2 ]
Kollar, Branislav [2 ]
Turcani, Peter [2 ]
机构：
[1] Slovak Acad Sci, Biomed Res Ctr, Bratislava, Slovakia
[2] Comenius Univ, Dept Neurol 1, Fac Med, Bratislava, Slovakia
来源：
NEUROTHERAPEUTICS | 2020年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
14
引用
收藏
页码：1316 / 1316
页数：1
相关论文
共 50 条
  • [21] GLP-1 Pathway drugs (Incretin Therapy) for Diabetes Melitus: Physiology, Clinical Rationale and Implications for the Exocrine Pancreas
    Fine, David
    PANCREATOLOGY, 2016, 16 (01) : 1 - 1
  • [22] GLP-1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea
    O'Donnell, Cliona
    Ryan, Odhran
    Hogan, Andrew E.
    Killick, Desmond
    Crilly, Shane
    Dodd, Jonathan D.
    Murphy, David J.
    Ryan, Silke
    O'Shea, Donal
    OBESITY, 2024, 32 (11) : 2077 - 2081
  • [23] Effect of the GLP-1 Receptor Agonist Exenatide on Impaired Awareness of Hypoglycemia in Type 1 Diabetes: A Randomized Controlled Trial
    van Meijel, Lian A.
    Rooijackers, Hanne M.
    Tack, Cees J.
    de Galan, Bastiaan E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (09): : 4143 - 4150
  • [24] Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics
    Nahvi S.
    Segal K.S.
    Litwin A.H.
    Arnsten J.H.
    Addiction Science & Clinical Practice, 9 (1)
  • [25] Light Therapy For The Treatment Of Multiple Sclerosis (MS) Associated Fatigue: A Randomized, Controlled Trial
    Vogel, A.
    Videnovic, A.
    Kaplan, T. B.
    Hotan, G. C.
    Stauder, M.
    Holroyd, K.
    Manalo, N.
    Mateen, F. J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 148 - 148
  • [26] The OPTIMIZE trial: Rationale and design of a randomized controlled trial of motivational enhancement therapy to improve adherence to statin medication
    Rash, Joshua A.
    Lavoie, Kim L.
    Sigal, Ronald J.
    Campbell, David J. T.
    Manns, Braden J.
    Tonelli, Marcello
    Campbell, Tavis S.
    CONTEMPORARY CLINICAL TRIALS, 2016, 49 : 47 - 56
  • [27] The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial
    Nosworthy, JH
    Ebers, GC
    Vandervoort, MK
    Farquhar, RE
    Yetisir, E
    Roberts, R
    NEUROLOGY, 2001, 57 (12) : S31 - S35
  • [28] Achillea millefolium is beneficial as an add-on therapy in patients with multiple sclerosis: A randomized placebo-controlled clinical trial
    Ayoobi, Fatemeh
    Moghadam-Ahmadi, Amir
    Amiri, Houshang
    Vakilian, Alireza
    Heidari, Moslem
    Farahmand, Habib
    Fathollahi, Mahmood Sheikh
    Fatemi, Imam
    Shafiei, Seyed Ali
    Alahtavakoli, Mohammad
    Shamsizadeh, Ali
    PHYTOMEDICINE, 2019, 52 : 89 - 97
  • [29] Rationale and Design of the Traditional Versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) Trial
    Mowry, Ellen M.
    Cassard, Sandra D.
    Shoemaker, Thomas
    Ogburn, Elizabeth L.
    Prince, Jerry
    Newsome, Scott D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 27 - 27
  • [30] Rationale, design, and methods: A randomized placebo-controlled trial of an immunomodulatory probiotic intervention for Veterans with PTSD
    Brenner, Lisa A.
    Stearns-Yoder, Kelly A.
    Stamper, Christopher E.
    Hoisington, Andrew J.
    Brostow, Diana P.
    Hoffmire, Claire A.
    Forster, Jeri E.
    Donovan, Meghan L.
    Ryan, Arthur T.
    Postolache, Teodor T.
    Lowry, Christopher A.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 28
12345